control group:Western medicine standard treatment
Sponsors
Longhua Hospital Shanghai University of Traditional Chinese Medicine, Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Guangdong Provincial Hospital of Traditional Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Dongzhimen Hospital affiliated to Beijing University of Chinese Medicine
Conditions
Acute kidney injury associated with immune checkpoint inhibitorsDiabetic FootDiabetic Kidney DiseaseHypertensive CardiopathyNovel Coronavirus Pneumonia (COVID-19)Sepsis
Early Phase 1
Clinical Study on Sepsis with Integrated Traditional Chinese and Western Medicine
RecruitingITMCTR2000004173
Start: 2021-01-01Updated: 2023-02-20
Clinical Study on Sepsis with Integrated Traditional Chinese and Western Medicine
RecruitingChiCTR2000041067
Start: 2021-01-01Updated: 2021-03-01
A randomized, double-blind, placebo-controlled trial for Xinguan Fuzheng Zhuanyin Decoction to reduce the viral load of the delta variant of COVID-19
RecruitingChiCTR2100047596
Start: 2021-06-18Updated: 2022-02-21
A randomized, double-blind, placebo-controlled trial for Xinguan Fuzheng Zhuanyin Decoction to reduce the viral load of the delta variant of COVID-19
RecruitingITMCTR2100004966
Start: 2021-06-18Updated: 2023-02-20
Phase 4
Unknown Phase
Clinical study on treatment of diabetic foot with integrated traditional Chinese and western medicine
RecruitingChiCTR2000039382
Start: 2020-11-01Updated: 2021-02-01
Clinical study on treatment of diabetic foot with integrated traditional Chinese and western medicine
RecruitingITMCTR2100004331
Start: 2020-11-01Updated: 2023-02-20
Based on the clinical research platform of traditional Chinese medicine (TCM) the evidence-based study on the prevention and treatment of rapidly progressive diabetic kidney disease (DKD) by optimizing the scheme ofTonifying kidney filling qi dredging collaterals and eliminating symptoms
RecruitingITMCTR2025000242
Start: 2024-09-01Updated: 2025-03-03
Clinical evidence-based evaluation of the treatment of ICIs-AKI of qi deficiency and blood stasis type with Hushen Xiaoyu Mixture
Active, not recruitingITMCTR2026000337
Start: 2026-11-01Updated: 2026-03-02